| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740939 | Journal of Microbiology, Immunology and Infection | 2018 | 5 Pages |
Abstract
The higher 14-day mortality rate for patients with Acinetobacter bacteremia receiving tigecycline appropriately compared to other appropriate antibiotics (36.4% versus 14.2%, P = 0.028) was due to the poor effect of tigecycline for isolates with a minimum inhibitory concentration of 2 μg/mL (63.6% of 11 versus 14.2% of 127, P = 0.001).
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yea-Yuan Chang, Yuag-Meng Liu, Chang-Pan Liu, Shu-Chen Kuo, Te-Li Chen,